NVCT vs SWKS · $304.5M cap vs P/E 29, rev $4.09B
Nuvectis Pharma Inc (NVCT) versus Skyworks Solutions Inc (SWKS) — a side-by-side from cached financials, not a winner call.
Nuvectis Pharma Inc (NVCT) is a biotechnology company listed on NASDAQ.
Skyworks Solutions Inc (SWKS) is a semiconductors company listed on NASDAQ.
NVCT does not have a complete income-statement cache yet.
Latest reported SWKS revenue for 2025-10-03 was $4.09B. Net income was $477.1M. SWKS currently screens at market cap $10.44B and trailing P/E 28.9.
NVCT currently screens at market cap $304.5M. SWKS currently screens at market cap $10.44B and trailing P/E 28.9.
Not investment advice. Open the NVCT and SWKS stock pages for the full models.
Not investment advice.